MARKET

SONN

SONN

Sonnet Biotherapeutc Hldng Inc
NASDAQ
3.070
-0.140
-4.36%
After Hours: 3.069 -0.001 -0.02% 20:05 09/22 EDT
OPEN
3.259
PREV CLOSE
3.210
HIGH
3.300
LOW
3.020
VOLUME
50.21K
TURNOVER
0
52 WEEK HIGH
66.00
52 WEEK LOW
3.020
MARKET CAP
5.37M
P/E (TTM)
-0.0473
1D
5D
1M
3M
1Y
5Y
Sonnet BioTherapeutics files for offering of shares and warrants
Seeking Alpha · 4d ago
Sonoma Pharmaceuticals files for offering of 5M shares
Seeking Alpha · 4d ago
Sonnet Biotherapeutc Hldng Inc: General form for registration of securities under the Securities Act of 1933
Press release · 5d ago
Sonnet BioTherapeutics regains listing compliance
Seeking Alpha · 5d ago
Sonnet BioTherapeutics Regains Nasdaq Minimum Bid Price Compliance
Benzinga · 5d ago
Weekly Report: what happened at SONN last week (0911-0915)?
Weekly Report · 6d ago
Weekly Report: what happened at SONN last week (0904-0908)?
Weekly Report · 09/11 12:26
Sonnet BioTherapeutics Implements Reverse Stock Split
NASDAQ · 09/01 09:23
More
About SONN
Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage, oncology-focused biotechnology company. The Company's technology, namely Fully Human Albumin Binding (FHAB), utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The Company designed the FHAB construct to improve drug accumulation in cancer tumors, as well as to extend the duration of activity in the body. Its lead asset, SON-1010, is a fully human single-chain version of Interleukin 12 (IL-12), covalently linked to the FHAB construct, for which it is pursuing clinical development in solid tumors. Its lead clinical-stage asset, SON-080, is a fully human version of IL-6 manufactured in Chinese Hamster Ovary (CHO) cells. SON-080, for its target indications of Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Diabetic Peripheral Neuropathy (DPN). Its pipeline also includes SON-1210, SON-1410 and SON-3015.

Webull offers kinds of Sonnet Biotherapeutics Holdings Inc stock information, including NASDAQ:SONN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SONN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SONN stock methods without spending real money on the virtual paper trading platform.